Artefact Projects Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:35 pm

Quick Insight

Artefact Projects Ltd, with a current share price of ₹72.4 and a market cap of 52.7 Cr., presents an intriguing investment opportunity in the infrastructure sector. The company's low P/E ratio of 7.23 indicates potential undervaluation, while its robust ROE of 11.7% and ROCE of 13.4% demonstrate efficient capital utilization. With a healthy operating profit margin of 18.05% and a solid reserve base of 58.40 Cr., Artefact Projects shows financial stability. However, the concerning ICR of 0.21x raises liquidity issues, and the high promoter holding of 39.09% may limit future growth potential. Investors should closely monitor the company's ability to manage its borrowings and improve its ICR to ensure long-term sustainability.

Competitors of Artefact Projects Ltd

All Competitor Stocks of Artefact Projects Ltd

Quarterly Result

Last Updated: August 1, 2025, 7:25 am

Below is a detailed analysis of the quarterly data for Artefact Projects Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 12.74 Cr.. The value appears strong and on an upward trend. It has increased from 7.33 Cr. (Dec 2024) to 12.74 Cr., marking an increase of 5.41 Cr..
• For Expenses, as of Mar 2025, the value is 10.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.36 Cr. (Dec 2024) to 10.44 Cr., marking an increase of 5.08 Cr..
• For Operating Profit, as of Mar 2025, the value is 2.30 Cr.. The value appears strong and on an upward trend. It has increased from 1.97 Cr. (Dec 2024) to 2.30 Cr., marking an increase of 0.33 Cr..
• For OPM %, as of Mar 2025, the value is 18.05%. The value appears to be declining and may need further review. It has decreased from 26.88% (Dec 2024) to 18.05%, marking a decrease of 8.83%.
• For Other Income, as of Mar 2025, the value is 1.30 Cr.. The value appears strong and on an upward trend. It has increased from 0.26 Cr. (Dec 2024) to 1.30 Cr., marking an increase of 1.04 Cr..
• For Interest, as of Mar 2025, the value is 0.42 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.42 Cr..
• For Depreciation, as of Mar 2025, the value is 0.11 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.11 Cr..
• For Profit before tax, as of Mar 2025, the value is 3.07 Cr.. The value appears strong and on an upward trend. It has increased from 1.70 Cr. (Dec 2024) to 3.07 Cr., marking an increase of 1.37 Cr..
• For Tax %, as of Mar 2025, the value is 2.93%. The value appears to be improving (decreasing) as expected. It has decreased from 27.06% (Dec 2024) to 2.93%, marking a decrease of 24.13%.
• For Net Profit, as of Mar 2025, the value is 2.98 Cr.. The value appears strong and on an upward trend. It has increased from 1.24 Cr. (Dec 2024) to 2.98 Cr., marking an increase of 1.74 Cr..
• For EPS in Rs, as of Mar 2025, the value is 4.10. The value appears strong and on an upward trend. It has increased from 1.70 (Dec 2024) to 4.10, marking an increase of 2.40.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:54 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:51 pm

Below is a detailed analysis of the balance sheet data for Artefact Projects Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 7.28 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.28 Cr..
• For Reserves, as of Mar 2025, the value is 58.40 Cr.. The value appears strong and on an upward trend. It has increased from 52.01 Cr. (Mar 2024) to 58.40 Cr., marking an increase of 6.39 Cr..
• For Borrowings, as of Mar 2025, the value is 14.64 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 10.08 Cr. (Mar 2024) to 14.64 Cr., marking an increase of 4.56 Cr..
• For Other Liabilities, as of Mar 2025, the value is 22.24 Cr.. The value appears to be improving (decreasing). It has decreased from 28.80 Cr. (Mar 2024) to 22.24 Cr., marking a decrease of 6.56 Cr..
• For Total Liabilities, as of Mar 2025, the value is 102.56 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 98.17 Cr. (Mar 2024) to 102.56 Cr., marking an increase of 4.39 Cr..
• For Fixed Assets, as of Mar 2025, the value is 13.24 Cr.. The value appears strong and on an upward trend. It has increased from 11.87 Cr. (Mar 2024) to 13.24 Cr., marking an increase of 1.37 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 13.06 Cr. (Mar 2024) to 0.16 Cr., marking a decrease of 12.90 Cr..
• For Other Assets, as of Mar 2025, the value is 89.16 Cr.. The value appears strong and on an upward trend. It has increased from 73.24 Cr. (Mar 2024) to 89.16 Cr., marking an increase of 15.92 Cr..
• For Total Assets, as of Mar 2025, the value is 102.56 Cr.. The value appears strong and on an upward trend. It has increased from 98.17 Cr. (Mar 2024) to 102.56 Cr., marking an increase of 4.39 Cr..

Notably, the Reserves (58.40 Cr.) exceed the Borrowings (14.64 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Artefact Projects Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 16, the value is -9.26. This value is below the healthy minimum of 5. It has decreased from 3.40 (Mar 15) to -9.26, marking a decrease of 12.66.
• For Diluted EPS (Rs.), as of Mar 16, the value is -9.26. This value is below the healthy minimum of 5. It has decreased from 3.40 (Mar 15) to -9.26, marking a decrease of 12.66.
• For Cash EPS (Rs.), as of Mar 16, the value is -7.61. This value is below the healthy minimum of 3. It has decreased from 5.18 (Mar 15) to -7.61, marking a decrease of 12.79.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 63.88. It has decreased from 72.77 (Mar 15) to 63.88, marking a decrease of 8.89.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 63.88. It has decreased from 72.77 (Mar 15) to 63.88, marking a decrease of 8.89.
• For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 53.95. It has decreased from 84.45 (Mar 15) to 53.95, marking a decrease of 30.50.
• For PBDIT / Share (Rs.), as of Mar 16, the value is 1.84. This value is below the healthy minimum of 2. It has decreased from 14.41 (Mar 15) to 1.84, marking a decrease of 12.57.
• For PBIT / Share (Rs.), as of Mar 16, the value is 0.18. This value is within the healthy range. It has decreased from 12.67 (Mar 15) to 0.18, marking a decrease of 12.49.
• For PBT / Share (Rs.), as of Mar 16, the value is -8.49. This value is below the healthy minimum of 0. It has decreased from 5.29 (Mar 15) to -8.49, marking a decrease of 13.78.
• For Net Profit / Share (Rs.), as of Mar 16, the value is -9.27. This value is below the healthy minimum of 2. It has decreased from 3.44 (Mar 15) to -9.27, marking a decrease of 12.71.
• For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is -9.26. This value is below the healthy minimum of 2. It has decreased from 3.40 (Mar 15) to -9.26, marking a decrease of 12.66.
• For PBDIT Margin (%), as of Mar 16, the value is 3.41. This value is below the healthy minimum of 10. It has decreased from 17.06 (Mar 15) to 3.41, marking a decrease of 13.65.
• For PBIT Margin (%), as of Mar 16, the value is 0.33. This value is below the healthy minimum of 10. It has decreased from 14.99 (Mar 15) to 0.33, marking a decrease of 14.66.
• For PBT Margin (%), as of Mar 16, the value is -15.73. This value is below the healthy minimum of 10. It has decreased from 6.25 (Mar 15) to -15.73, marking a decrease of 21.98.
• For Net Profit Margin (%), as of Mar 16, the value is -17.19. This value is below the healthy minimum of 5. It has decreased from 4.07 (Mar 15) to -17.19, marking a decrease of 21.26.
• For NP After MI And SOA Margin (%), as of Mar 16, the value is -17.17. This value is below the healthy minimum of 8. It has decreased from 4.02 (Mar 15) to -17.17, marking a decrease of 21.19.
• For Return on Networth / Equity (%), as of Mar 16, the value is -14.50. This value is below the healthy minimum of 15. It has decreased from 4.67 (Mar 15) to -14.50, marking a decrease of 19.17.
• For Return on Capital Employeed (%), as of Mar 16, the value is 0.17. This value is below the healthy minimum of 10. It has decreased from 15.32 (Mar 15) to 0.17, marking a decrease of 15.15.
• For Return On Assets (%), as of Mar 16, the value is -5.48. This value is below the healthy minimum of 5. It has decreased from 2.02 (Mar 15) to -5.48, marking a decrease of 7.50.
• For Long Term Debt / Equity (X), as of Mar 16, the value is 0.52. This value is within the healthy range. It has increased from 0.08 (Mar 15) to 0.52, marking an increase of 0.44.
• For Total Debt / Equity (X), as of Mar 16, the value is 0.88. This value is within the healthy range. It has increased from 0.37 (Mar 15) to 0.88, marking an increase of 0.51.
• For Asset Turnover Ratio (%), as of Mar 16, the value is 0.19. It has decreased from 0.25 (Mar 15) to 0.19, marking a decrease of 0.06.
• For Current Ratio (X), as of Mar 16, the value is 1.46. This value is below the healthy minimum of 1.5. It has increased from 1.21 (Mar 15) to 1.46, marking an increase of 0.25.
• For Quick Ratio (X), as of Mar 16, the value is 1.34. This value is within the healthy range. It has increased from 1.09 (Mar 15) to 1.34, marking an increase of 0.25.
• For Dividend Payout Ratio (NP) (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 15) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 15) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 15) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 15) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 16, the value is 0.21. This value is below the healthy minimum of 3. It has decreased from 1.95 (Mar 15) to 0.21, marking a decrease of 1.74.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is -0.06. This value is below the healthy minimum of 3. It has decreased from 1.47 (Mar 15) to -0.06, marking a decrease of 1.53.
• For Enterprise Value (Cr.), as of Mar 16, the value is 47.63. It has increased from 31.30 (Mar 15) to 47.63, marking an increase of 16.33.
• For EV / Net Operating Revenue (X), as of Mar 16, the value is 1.60. This value is within the healthy range. It has increased from 0.67 (Mar 15) to 1.60, marking an increase of 0.93.
• For EV / EBITDA (X), as of Mar 16, the value is 46.86. This value exceeds the healthy maximum of 15. It has increased from 3.93 (Mar 15) to 46.86, marking an increase of 42.93.
• For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 15) to 0.59, marking an increase of 0.16.
• For Retention Ratios (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 15) which recorded 0.00.
• For Price / BV (X), as of Mar 16, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 15) which recorded 0.50.
• For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 15) to 0.59, marking an increase of 0.16.
• For EarningsYield, as of Mar 16, the value is -0.28. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 15) to -0.28, marking a decrease of 0.37.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness